Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trial
瑞戈非尼治疗既往接受过治疗的晚期黑色素瘤患者的疗效和安全性：RegoMel II期临床试验结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106941
Dirven, I; Bertels, C; Moreels, Y; Kessels, J I; Vanlaer, N; Vander Mijnsbrugge, A-S; Vounckx, M; Dirks, I; Raes, L; Geeraerts, X; Stevens, L; von Kemp, B; Fasolino, G; Awada, G; Janssen, T; Caljon, B; Lefevre, T; Everaert, H; Rogiers, A; Vandemeulebroucke, J; Tuyaerts, S; Neyns, B
